Search results
Results from the WOW.Com Content Network
A systematic review update in 2022 demonstrated that pregnant women are at increased risk of severe COVID-19. It also found that risk factors for severe COVID-19 in pregnant people included high body mass index, being of an older age, being of non-white ethnic origin, having pre-existing comorbidities, having pre-eclampsia or gestational diabetes.
Dexamethasone is a fluorinated glucocorticoid medication [10] used to treat rheumatic problems, a number of skin diseases, severe allergies, asthma, chronic obstructive pulmonary disease (COPD), croup, brain swelling, eye pain following eye surgery, superior vena cava syndrome (a complication of some forms of cancer), [11] and along with antibiotics in tuberculosis. [10]
The principal for obstetric management of COVID-19 include rapid detection, isolation, and testing, profound preventive measures, regular monitoring of fetus as well as of uterine contractions, peculiar case-to-case delivery planning based on severity of symptoms, and appropriate post-natal measures for preventing infection.
Dexamethasone, a cheap and widely available steroid, may be a good treatment for patients with severe COVID-19—but not milder cases. Dexamethasone, a cheap and widely available steroid, may be a ...
Getting vaccinated during pregnancy, she added, tends to give newborns higher antibody levels than a Covid infection in pregnancy does, so even pregnant mothers who get Covid should get the shot ...
The results drew scepticism and optimism alike and put the focus on the availability of dexamethasone. South Africa's Aspen could supply 10 million dexamethasone pills in COVID-19 crisis Skip to ...
Coronavirus disease 2019 (COVID-19) is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic . The symptoms of COVID‑19 can vary but often include fever, [ 7 ] fatigue, cough, breathing difficulties , loss of smell , and loss of taste .
Mortality over 28 days for 1535 COVID-19 patients not receiving oxygen at time of randomisation: 501 patients who received dexamethasone (red) compared to 1034 who received standard hospital care (black) [18] John Fletcher, research editor at the BMJ, noted that there were "limitations and causes of concern" in the dexamethasone results. [22]